NERM
STJ

New England Research & Management’s St Jude Medical STJ Stock Holding History

New England Research & Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,025
Closed -$331K – 180
2016
Q1 		$331K Hold
6,025
– – 0.28% 116
2015
Q4 		$372K Sell
6,025
-400
-6% -$25.2K 0.32% 109
2015
Q3 		$405K Buy
+6,425
New +$459K 0.39% 96
2015
Q2 		– Sell
-5,925
Closed -$387K – 201
2015
Q1 		$387K Buy
+5,925
New +$394K 0.33% 116

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

New England Research & Management's STJ Position: Q2 2016 in Review

New England Research & Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 6,025 shares — an estimated $331K sold.

New England Research & Management first reported a position in STJ in Q1 2015 and held it in 4 quarters. The position peaked at $405K in Q3 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • New England Research & Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • New England Research & Management sold 6,025 St Jude Medical shares in Q2 2016, an estimated $331K.
  • New England Research & Management first reported a position in St Jude Medical in Q1 2015 and held it in 4 quarters.
  • New England Research & Management's St Jude Medical position peaked at $405K in Q3 2015.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.